SynthesisFrontiers in immunology2022

Determining the Optimal (Neo)Adjuvant Regimen for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Regarding Survival Outcome: A Network Meta-Analysis.

Yu-Wen Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.